| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A contemporary downtrend in chronic GVHD?
|
El Jurdi, Najla
|
|
|
8 |
22 |
p. 5875-5877
|
artikel
|
| 2 |
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis
|
Lin, Chenyu
|
|
|
8 |
22 |
p. 5735-5743
|
artikel
|
| 3 |
Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments
|
Leung, Halina H. L.
|
|
|
8 |
22 |
p. 5744-5752
|
artikel
|
| 4 |
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells
|
Kocoglu, Mehmet H.
|
|
|
8 |
22 |
p. 5880-5884
|
artikel
|
| 5 |
Decreasing chronic graft-versus-host disease rates in all populations
|
Carpenter, Paul A.
|
|
|
8 |
22 |
p. 5829-5837
|
artikel
|
| 6 |
Defying the odds: 30 years in AL amyloidosis research—recent barriers to clinical trial enrollment
|
Sanchorawala, Vaishali
|
|
|
8 |
22 |
p. 5826-5828
|
artikel
|
| 7 |
Diabetes mellitus, metformin, and the risk of MPN
|
Krecak, Ivan
|
|
|
8 |
22 |
p. 5929-5931
|
artikel
|
| 8 |
Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial
|
Mejias, Jose
|
|
|
8 |
22 |
p. 5853-5854
|
artikel
|
| 9 |
Glisovic-Aplenc T, Diorio C, Chukinas JA, et al. CD38 as a pan-hematologic target for chimeric antigen receptor T cells. Blood Adv. 2023;7(16):4418-4430.
|
|
|
|
8 |
22 |
p. 5789
|
artikel
|
| 10 |
Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing
|
Liu, Xiao-Qin
|
|
|
8 |
22 |
p. 5906-5916
|
artikel
|
| 11 |
Improving infection reporting in hematology treatment trials
|
Teh, Benjamin W.
|
|
|
8 |
22 |
p. 5925-5926
|
artikel
|
| 12 |
Improving reporting of infection events in clinical trials
|
Ludwig, Heinz
|
|
|
8 |
22 |
p. 5927-5928
|
artikel
|
| 13 |
Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.
|
|
|
|
8 |
22 |
p. 5766
|
artikel
|
| 14 |
Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor DLBCL
|
Kim, Sehui
|
|
|
8 |
22 |
p. 5773-5788
|
artikel
|
| 15 |
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms
|
Ozkaya, Neval
|
|
|
8 |
22 |
p. 5796-5805
|
artikel
|
| 16 |
In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbb th3/+) mice
|
Yu, Yang
|
|
|
8 |
22 |
p. 5753-5765
|
artikel
|
| 17 |
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice
|
La Mura, Vincenzo
|
|
|
8 |
22 |
p. 5725-5734
|
artikel
|
| 18 |
Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial
|
Mehta, Amitkumar
|
|
|
8 |
22 |
p. 5855-5863
|
artikel
|
| 19 |
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma
|
Maakaron, Joseph E.
|
|
|
8 |
22 |
p. 5864-5874
|
artikel
|
| 20 |
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial
|
Betensky, Marisol
|
|
|
8 |
22 |
p. 5790-5795
|
artikel
|
| 21 |
Pediatric adapted risk index to predict 2-year transplant-related mortality post-HSCT in children
|
Elfeky, Reem
|
|
|
8 |
22 |
p. 5838-5852
|
artikel
|
| 22 |
Platelet Ido1 expression is induced during Plasmodium yoelii infection, altering plasma tryptophan metabolites
|
Blick-Nitko, Sara K.
|
|
|
8 |
22 |
p. 5814-5825
|
artikel
|
| 23 |
Predictors of liver disease outcomes in individuals with hemophilia and HCV infection
|
Christodoulou, Ilias
|
|
|
8 |
22 |
p. 5767-5772
|
artikel
|
| 24 |
Psychological burden and depressive symptoms in caregivers of hemato-oncological patients: the role of medical visits
|
Abed Al Wahad, Ali
|
|
|
8 |
22 |
p. 5917-5924
|
artikel
|
| 25 |
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort
|
Poston, Jacqueline N.
|
|
|
8 |
22 |
p. 5896-5905
|
artikel
|
| 26 |
Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax
|
Valtis, Yannis K.
|
|
|
8 |
22 |
p. 5806-5813
|
artikel
|
| 27 |
Sewastianik T, Jiang M, Sukhdeo K, et al. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice. Blood Adv. 2017;1(25):2361-2374.
|
|
|
|
8 |
22 |
p. 5878-5879
|
artikel
|
| 28 |
The use of metformin and risk of myeloproliferative neoplasms among patients with no registered markers of diabetes
|
Kristensen, Daniel Tuyet
|
|
|
8 |
22 |
p. 5932-5934
|
artikel
|
| 29 |
UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease
|
Liu, Boya
|
|
|
8 |
22 |
p. 5885-5895
|
artikel
|
Tijdschrift beschrijving